CD8-α Antibodies

Santa Cruz Biotechnology offers a broad range of CD8-α monoclonal antibodies for immunology and cell biology research. CD8-α monoclonal antibodies perform effectively in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD8-α is a critical component of the CD8 glycoprotein complex, which plays a vital role in the immune response by identifying and eliminating infected or cancerous cells. CD8-α is primarily expressed on cytotoxic T cells, where it functions as a co-receptor that enhances the interaction between T cells and antigen-presenting cells. Understanding CD8-α functionality is essential for advancing therapeutic strategies in cancer immunotherapy and infectious disease management. Research involving CD8-α has led to significant discoveries in T cell development, activation, and function. Investigating CD8-α expression patterns and interactions continues to reveal new insights into immune system regulation. Santa Cruz Biotechnology monoclonal antibodies for CD8-α enable researchers worldwide to advance scientific understanding of immune responses and cellular mechanisms.